United States · FDA National Drug Code directory
Travoprost ophthalmic solution
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62332-625_64811638-2446-4b3c-b71f-f3e8321f4230
- Product NDC
- 62332-625
- Form
- SOLUTION/ DROPS
- Composition / generic term
- Travoprost ophthalmic
- Labeler
- Alembic Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251217
- Source listing expiry
- 20261231
Source-listed ingredients
- TRAVOPROST — .04 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (62332-625-02) / 2.5 mL in 1 BOTTLE · 62332-625-02
- 1 BOTTLE in 1 CARTON (62332-625-05) / 5 mL in 1 BOTTLE · 62332-625-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →